GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Life Sciences Investors (NYSE:HQL) » Definitions » PS Ratio

abrdn Life Sciences Investors (abrdn Life Sciences Investors) PS Ratio : 13.98 (As of Apr. 26, 2024)


View and export this data going back to . Start your Free Trial

What is abrdn Life Sciences Investors PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, abrdn Life Sciences Investors's share price is $13.00. abrdn Life Sciences Investors's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.93. Hence, abrdn Life Sciences Investors's PS Ratio for today is 13.98.

Warning Sign:

abrdn Life Sciences Investors stock PS Ratio (=15.58) is close to 10-year high of 17.04

The historical rank and industry rank for abrdn Life Sciences Investors's PS Ratio or its related term are showing as below:

HQL' s PS Ratio Range Over the Past 10 Years
Min: 3.25   Med: 6.17   Max: 17.04
Current: 14.02

During the past 7 years, abrdn Life Sciences Investors's highest PS Ratio was 17.04. The lowest was 3.25. And the median was 6.17.

HQL's PS Ratio is ranked worse than
67.33% of 1411 companies
in the Asset Management industry
Industry Median: 8.26 vs HQL: 14.02

abrdn Life Sciences Investors's Revenue per Sharefor the six months ended in Sep. 2023 was $-0.36. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.93.

Warning Sign:

abrdn Life Sciences Investors revenue per share has been in decline over the past 3 years.

During the past 3 years, the average Revenue per Share Growth Rate was -45.70% per year.

During the past 7 years, abrdn Life Sciences Investors's highest 3-Year average Revenue per Share Growth Rate was 28.40% per year. The lowest was -45.70% per year. And the median was 3.30% per year.

Back to Basics: PS Ratio


abrdn Life Sciences Investors PS Ratio Historical Data

The historical data trend for abrdn Life Sciences Investors's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Life Sciences Investors PS Ratio Chart

abrdn Life Sciences Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
PS Ratio
Get a 7-Day Free Trial - 3.38 7.68 - 15.01

abrdn Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.68 - - - 15.01

Competitive Comparison of abrdn Life Sciences Investors's PS Ratio

For the Asset Management subindustry, abrdn Life Sciences Investors's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Life Sciences Investors's PS Ratio Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's PS Ratio distribution charts can be found below:

* The bar in red indicates where abrdn Life Sciences Investors's PS Ratio falls into.



abrdn Life Sciences Investors PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

abrdn Life Sciences Investors's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=13.00/0.93
=13.98

abrdn Life Sciences Investors's Share Price of today is $13.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Life Sciences Investors's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.93.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


abrdn Life Sciences Investors  (NYSE:HQL) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


abrdn Life Sciences Investors PS Ratio Related Terms

Thank you for viewing the detailed overview of abrdn Life Sciences Investors's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Life Sciences Investors (abrdn Life Sciences Investors) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Executives
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022

abrdn Life Sciences Investors (abrdn Life Sciences Investors) Headlines

From GuruFocus

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 12-30-2022

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 11-12-2021

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 08-17-2021

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 05-17-2022

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 03-31-2023

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 08-16-2022

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 06-30-2020

Tekla Life Sciences Investors Paid Distribution

By Business Wire 06-30-2023